EICHORCondition: Dental Caries · Sponsor: Colgate Palmolive
The objective of this study is to assess the safety and to evaluate the anti-caries efficacy of COL101 (arginine) non-fluoride dentifrices compared to a 0.24% sodium fluoride dentifrice in 10-14 year-old children over a one year period.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Loma Linda University School of Dentistry | Loma Linda, California, United States | — |
| University of Florida College of Dentistry | Gainesville, Florida, United States | — |
| Indiana University School of Dentistry | Indianapolis, Indiana, United States | — |
| Tufts University School of Dental Medicine | Boston, Massachusetts, United States | — |
| The Forsyth Institute | Boston, Massachusetts, United States | — |
| University at Buffalo School of Dental Medicine | Buffalo, New York, United States | — |
| University of Pennsylvania School of Dental Medicine | Philadelphia, Pennsylvania, United States | — |
| UT Health San Antonio School of Dentistry | San Antonio, Texas, United States | — |
| University of Puerto Rico School of Dental Medicine | San Juan, Puerto Rico | — |
Sponsor or site team? See the site landscape for this trial — listed sites, countries, and recruiting-density context.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04750902